Bellicum Pharmaceuticals, Inc.
METHODS FOR ENHANCING AND MAINTAINING CAR-T CELL EFFICACY

Last updated:

Abstract:

The technology relates generally to the field of immunology and relates in part to compositions and methods for activating T cells and other cells resulting in an immune response against a target antigen. The technology also relates to compositions and methods for enhancing and maintaining chimeric antigen receptor-expressing T cells, while reducing cytotoxic effects of CAR-T cell therapies

Status:
Application
Type:

Utility

Filling date:

7 Dec 2018

Issue date:

5 Nov 2020